Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services

Allocation of Bamlanivimab by Jurisdiction

Bamlanivimab is allocated by the federal government to states, territories, and federal entities on a weekly basis.

 

States / Territories / Federal Entities Week 1
(Nov 9 - 17)
Phase 1 (patient courses)
Week 2
(Nov 18 - 23)
Phase 1 (patient courses)
Week 3
(Nov. 24 - Dec 1)
Phase 2 (patient courses)
Alabama1,080
500610
Alaska240
120120
American Samoa10
00
Arizona1,250
630970
Arkansas
950
450530
​Bureau of Prisons
​100
00
California
4,040
2,2503,230
Colorado1,980
1,0801,320
Commonwealth of the Northern Mariana Islands 10
010
Connecticut 600
420510
Delaware 140
90120
Department of Defense 300
0200
​Department of State
50
00
District of Columbia 90
5060
Federated States of Micronesia 10
00
Florida 3,890
1,7302,230
Georgia 1,920
8601,010
Guam 50
10050
Hawaii 80
3040
HHS00100
Idaho 680
290330
Illinois 6,380
2,9303,160
Indiana2,750
1,4801,700
Indian Health Service 300
0200
Iowa 2,110
1,0301,030
Kansas 1,330
700780
Kentucky 1,980
9201,140
Louisiana 690
540620
Maine 90
5060
Maryland 840
520710
​Massachusetts 1,020
560670
Michigan 3,240
1,7402,090
Minnesota 2,400
1,4001,580
​Mississippi
660
330420
Missouri 2,440
1,2301,410
Montana 710
310370
Nebraska 1,170
570630
Nevada 800
470590
New Hampshire 100
70100
New Jersey 1,550
9801,200
New Mexico 750
340590
New York 2,140
1,3501,670
NIH0500
North Carolina 1,690
740970
North Dakota 770
290320
Ohio 3,420
1,9002,330
Oklahoma 1,230
770940
Oregon 430
230300
​Palau 10
00
Pennsylvania 2,300
1,3801,870
Puerto Rico 640
180200
Republic of Marshall Islands1000
Rhode Island 310
160210
South Carolina 800
360410
South Dakota 820
340340
Tennessee 1,900
1,0801,170
Texas 5,780
3,1903,840
Utah 1,300
600750
Vermont 20
2030
Veteran's Affairs
300
0200
Virgin Islands 10
1010
Virginia 1,010
430620
Washington 720
410430
​West Virginia 370
100260
Wisconsin 4,260
1,8601,990
Wyoming 330
160200
Total (vials) 79,350
40,380 49,550


Total Monoclonal Antibody Therapeutics Allocated to Date

Product Total Allocation
(patient courses)

Bamlanivimab

169,780

Casirivimab/imdevimab 

36,072

Total Allocations

205,852

  • This page last reviewed: November 25, 2020